TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Singapore SC dismisses Singh bros’ appeal against HC order

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, May 29

Advertisement

The Singapore Supreme Court has dismissed an appeal by erstwhile Ranbaxy Laboratories’ former promoters Malvinder Singh and Shivinder Singh against a high court order that declined to set aside an arbitration award in favour of Japan’s Daichii Sankyo.

Advertisement

Confirming the development, Anand Pathak, Managing Partner P&A Law Offices, representing Japanese pharma firm Daaichi Sankyo said, “The Singapore Supreme Court has dismissed the appeal.” He further said, “We have been trying to enforce the award and we will continue in a very focused way to enforce the award, now that there is a finality to the appeal.” With interests and everything, the total amount is in excess of Rs 3,500 crore, Pathak said. — PTI

Advertisement
Show comments
Advertisement